News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News ACC 2023 IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF L.A. McKeown March 14, 2023
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Conference News ACC 2022 Tailored Nutrition Advice at the Grocery Store Works: SuperWIN Caitlin E. Cox April 03, 2022
News Conference News ACC 2019 CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year Yael L. Maxwell March 20, 2019
News Conference News ACC 2019 POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis L.A. McKeown March 18, 2019
News Conference News ACC 2018 Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS Caitlin E. Cox March 11, 2018
News Conference News ACC 2016 STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Discrimination Still Runs Rampant for Women in Cardiology Yael L. Maxwell April 02, 2016
News Conference News ACC 2015 Fellows-Focused Session Emphasizes Best Practices for Building a Career in Cardiology Yael L. Maxwell March 14, 2015
News Conference News ACC 2014 CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit April 02, 2014
News Conference News ACC 2014 CT Angiography Accurate, Less Expensive Than Treadmill in Diagnosing ER Chest Pain Jason Kahn March 29, 2014
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism L.A. McKeown March 26, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012